30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Cavanaugh Sarah

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 661%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Cavanaugh Sarah's trades of Celldex Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-03 2024-05-30
S Sale
41,264 +27.9%
202.24
US$4,675,453 		41,264 +27.9% 202.24 US$4,675,453
2024-05-30 2024-05-30
PrS Proposed sale
7,696
400.35
US$3,644,162 		7,696 400.35 US$3,644,162
2022-08-19 2022-08-18
S Sale
73,531 -8.3%
22.35
US$335,951 		73,531 -8.3% 22.35 US$335,951
2022-08-19 2022-08-17
S Sale
31,312 -96.1%
36.73
US$1,150,221 		31,312 -96.1% 36.73 US$1,150,221
2021-12-10 2021-12-08
PlS Planned sale
7,323 -94.7%
40.00
US$292,920 		7,323 -94.7% 40.00 US$292,920
2021-11-03 2021-11-01
PlS Planned sale
2,120 -83.9%
41.62
US$88,232 		2,120 -83.9% 41.62 US$88,232
2021-11-03 2021-11-01
PlS Planned sale
901 -26.3%
43.06
US$38,798 		901 -26.3% 43.06 US$38,798
2021-11-03 2021-11-01
PlS Planned sale
4,302 -55.6%
44.11
US$189,774 		4,302 -55.6% 44.11 US$189,774
2020-06-11 2020-06-10
B Purchase
1,050 +331.2%
4.83
US$5,072 		1,050 +331.2% 4.83 US$5,072